Fennerty A, Dolben J, Thomas P, Backhouse G, Bentley D P, Campbell I A, Routledge P A
Br Med J (Clin Res Ed). 1984 Apr 28;288(6426):1268-70. doi: 10.1136/bmj.288.6426.1268.
Fifty patients with venous thromboembolic disease being treated by heparin infusion received a three day warfarin induction regimen tailored according to the prothrombin time (British comparative ratio) measured on days 2 and 3. A prediction of the final maintenance dose of warfarin was made on the basis of a prothrombin time measured on day 4. All patients were safely anticoagulated by day 6, and the prediction was accurate to within 1 mg in 46 patients. Predicted and actual maintenance doses were closely related (r = 0.867; n = 50; p less than 0.001). This scheme should prove helpful in the control of anticoagulation, particularly in patients likely to be sensitive to warfarin, and should shorten hospital stay.
50例接受肝素静脉输注治疗的静脉血栓栓塞性疾病患者接受了为期3天的华法林诱导方案,该方案根据第2天和第3天测得的凝血酶原时间(英国对照比值)进行调整。根据第4天测得的凝血酶原时间对最终华法林维持剂量进行预测。到第6天时,所有患者均实现安全抗凝,46例患者的预测剂量与实际剂量相差不超过1mg。预测维持剂量与实际维持剂量密切相关(r = 0.867;n = 50;p < 0.001)。该方案在抗凝控制中应会有所帮助,尤其是对可能对华法林敏感的患者,并且应能缩短住院时间。